Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Cowtown,
How is Lenz administered?
Thanks
That is very helpful.
Thank you.
Is it possible to download all of the trade data? There are clearly patterns to how this stock trades and it would be interesting to analyze the raw data.
Ohm,
Thanks for the laugh!
CYDY - the only stock in the world that consistently goes down on positive news.
My vote Is $4.00 will not be a problem. I just got my popcorn ready and I’m in my easy chair getting ready for the Power Hour show to start. 5 minutes and counting....
Germany up 11%
https://www.bloomberg.com/quote/296:GR
3X,
I get the NP induced PTSD you, Grip, Saltz, and other long term investors feel. Heck, I’ve been here less than a year and I’m suffering from it as well. But I think Bucweet’s comments are very accurate about the healthcare system and costs.
My background includes 40 years in healthcare finance. When that CMS code was released it was a game changer for me. I have tried to get codes added and know how hard it is. While this is no guarantee of approval, it is as close as we are going to get before the results of CD12 are released.
I think NP is a crazy driver and from my view in the backseat he scares the crap out of me. However, it appears he MAY be able to get us successfully to our destination. Everything we see on the science side continues to validate Leronlimab.
We all got in a cab with a wild driver, at this point all the longs can do is close their eyes and hang on. I have a gut feeling we will be OK.
GLTU
I received the same information from Fidelity on loaning shares of CYDY at the same interest rate. After considering the offer, I was reminded of the Lenin saying, “When it comes time to hang the capitalists, they will vie with each other for the rope contract.”
I think it best we don’t help the shorts.
Chuckles,
I’m still in but I don’t have DM. If you can DM with your email, I will send you my contact information.
Thanks for all of your great work on this board.
Chuckles,
I love you sense of humor and sharp mind!
Keep it coming.
Cowtown Jay
I really appreciate your posts. Please keep sharing your respectful and well researched thoughts.
....and the CYDY jockey was clearly listed in the program when we bought our tickets to win. Let’s just hope Leronlimab is the horse we think it is, and it will run in spite of our weak jockey.
Great post from YMB.
Can you relate?
BDFR3 hours ago
Wanna know how absurdly awesome my investment in CYDY is.
CYDY has
19 employees plus or minus
0 revenues
O FDA approvals
I have
0 other investments
15 angry friends who I told invest in CYDY
2 months late mortgage
2 years late taxes
And yet...
This is by far the greatest investment I have ever made.
I would pay big money to get to fire NP personally.
That guy has to go!
Cowtown Jay
I’m really glad to see you posting on the CYDY board. I have followed you on the HGEN board and apprenticed your thoughtful posts. While I’m not long or short on HGEN, I have found you to be a good source of information on that stock.
Welcome to CYDY!
Great post from “Dave” on the Yahoo Message Board.
————————————————————————
Oldtimer here, 35-year investor. I don’t know how much longer I’ll be around. Getting old – I want my life to matter. You see I’d rather take a really f’ing hard swing at the plate than never get up to bat. I’m swinging hard at the plate w/CYDY (some on risk, but mostly on position size). I’m taking the risk in hopes of making a positive generational or two financial impact for those I’ll leave behind. I recently posted that I added 150,000 shares – wow did I get mocked, doubted, and blasted for that. The new CSO received 200,000 shares – I think he knows a lot more about CYDY than I do.
The last time I wrote the following the stock popped, so here’s to a repeat. CYDY is the most significant investment opportunity I’ve had in my lifetime. Sure, I’ve seen great companies grow and their SP’s skyrocket – but I wasn’t invested in those when they were on the cusp of their first breakout. I am with CYDY.
Current market awareness for CYDY/Leronlimab must be way less than 1% (market = medical, science, investment, human interest/media, yes political). STOP for a moment to think about that. As the level of interest grows, we will see a multiplying effect on the SP. The explosive trajectory of CYDY’s SP (in my opinion) will be like a runaway train (see, old-timer). Some traders will want to catch that train, the most successful investors are already on it. Congrats to those of us on board. Yes, there will be people who will repeatedly try and time the market and may miss the Gap Up.
My biggest investment mistakes which I share with you in hopes you’ll maximize your return on CYDY:
- I sold too quickly. Made 360% on TSLA (sold in 2018), 3420% if I continued to hold.
- My investment window was too short (trying to make $$ over a period of 1-3 months)
- I underestimated how high the stock price would go. Consider if Tesla paid out 100% of its current earnings as dividends an investor would breakeven in 1,128 years (SP/EPS - $440/$0.39. I know much more to consider, assets, growth and xx). Amazon 132 years. My point I’ll take CYDY.
- Not planning for the pullback. After the initial rise in CYDY’s SP, I know there will be a 30% pullback. I will not sell into that pullback. I’ve seen this way too many times and I’m convinced additional new highs are just a few days away. I’ll track the 10-day moving average, but my expectation is that any momentary 30% pullback will not breach the 10-day MA. It’s so easy to sell after a pullback but don’t. Ask the current long-term holders of AAPL, TESLA, and others. Consider that Proctor & Gamble went down 22% early in 2018, no long-term holder would sell at those low prices – what we’re going to sh_t and brush our teeth less? Those who bought at this level now have a 100% return - just 2-years later.
I read each post under the assumption the author holds 1 share of CYDY. I also assume all posters collectively hold 5% of outstanding shares. This helps me form and maintain my own opinion.
MY CONVICTION would not be so strong if it wasn’t for all the talented and thoughtful posters on this board – THANK YOU. I’ve learned so much about science and hope those individuals will keep us updated on their latest insights.
CONGRATS to us LONGS all we need to do when we check the SP is to sit on our hands (do nothing). Grandfatherly advice it’s always wise to have a plan – would you take some off the table at $25, $48, $85, $115, +?
MY best to you. In admiration of your insights.
C-20.
Just to add to your line of thinking, why would people who owned the stock but sold it, still be hanging around this board posting on a regular basis? Whenever I have sold a stock, I just moved on a seldom looked back. I can’t get my head around why a former long would invest so much time and effort into something they don’t own.
That makes no sense. No enrollment number between 0 and 390 is “100% impossible”.
Scooter may swing hard in both directions but his posts always contain good points to consider. Ignoring his posts both pro and con CYDY misses some very good DD.
Totally agree.
However we still need to vote NO on the compensation plan they have proposed for themselves. I find it a bit offensive when the try to grab 85M shares out of the new authorization of 100M shares. Those shares were to be used to fund clinical trials and capital requirements for uplisting. I feel like they have pulled a bait and switch on us.
Ombowstring - THANK YOU for sending this.
And that is why I voted NO.
It feels like they are viewing me as just another retail chump and not a loyal shareholder.
HGEN was at about $2 before the RS. The 5:1 RS split and uplisting has them at about $10 today. Neither the RS or uplisting have had a significant impact on their SP.
Even if we get uplisted next week, it really means nothing without some sort of approval. HGEN is a good example of that. The uplisting by itself has not moved their SP.
We need approvals and revenue to take off. Unfortunately, it seems to be the thing NP struggles to deliver.
I’m with you on the Patterson nomination for the Nobel But I’m thinking their may be some better choices than Nader for the Kalinga Prize.
https://en.m.wikipedia.org/wiki/Kalinga_Prize
Amen.
Is that really the only two choices we have?
Could we not have someone with good communication skills, the ability to focus, and HONEST transparency?
I understand only the FDA can approve.
All I ask from him is an HONEST update on where we are in the approval process. While he may not be technically lying to us, his routine omissions of key facts leave you with the impression that he is walking pretty close the non-truth line.
Rockleo,
I’m still with you here as a long. However, NP has lost my confidence and I will vote my shares to have him removed. The only way he regains my support is if he gets SOMETHING APPROVED.
I voted my shares today against the incentive plan and withheld my vote for NP as a board member.
I've moved over to the Grip camp on the future of NP.
Saltz,
I have to say it is interesting seeing you go short term bearish at the same time Grip is going bullish and buying back in (at least I think I saw a post to that affect). I’m not sure what all of that means other than we find ourselves in uncertain times in regards to events in the next several months.
Thanks
Thanks
It is my understanding that Mayo has/is submitting a paper for peer review. Do you know if that is just on the 12 patients or will include some of the other 139 patients?
Beyond the 12 Mayo patients, do we have clinical results on any other patients? Have there been any eIND patients?
I’m not saying it is a failure. I’m just saying the impact is smaller so the sample size needs to be bigger to achieve the required p value.
The red flag to me is the reason they gave for not doing the interim (having to pause enrollment). My guess would be they are concerned enough about the p value at 150 that they want to go to full enrollment to increase the odds of success. If the 12 Mayo patients were as successful as suggested in the study, a sample size of 150 should produce eye popping numbers.
Larger samples sizes are needed when the impact of a drug is smaller. It is the only way to get the required p value.
So if the results were great on the 12 patients, why not do an interim analysis on the 150 phase 3 patients? The numbers should be fantastic on the larger sample and provide the statistical basis for a EUA.
The reason given of having to stop enrollment during that analysis is not true.
I have been watching this stock for awhile and had considered buying. At this point I’m neither long or short in the stock.
If I was long and still believed in the company, I would sell now and re-enter at a lower price point. This stock is headed below $1. Preserve some of your capital while you still can.
Companies know who holds their shares and how many they have. That is the information they us whenever there is a shareholder vote.